Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

VaxGen Awarded $80.3M For Anthrax Vaccine Development

Oct. 2, 2003

By Aaron Lorenzo

VaxGen Awarded $80.3M For Anthrax Vaccine Development

Oct. 2, 2003

By Aaron Lorenzo

Pushing Its CNS Programs, Acorda Files For $75M IPO

Oct. 1, 2003

By Aaron Lorenzo

Inex Begins Rolling NDA For Onco TCS In Non-Hodgkin's

Oct. 1, 2003

By Aaron Lorenzo

Inex Begins Rolling NDA For Onco TCS In Non-Hodgkin's

Oct. 1, 2003

By Aaron Lorenzo

Pushing Its CNS Programs, Acorda Files For $75M IPO

Oct. 1, 2003

By Aaron Lorenzo

NIH Disperses Nearly $90M For HIV Vaccines, Other Diseases

Sep. 30, 2003

By Aaron Lorenzo

NIH Disperses Nearly $90M For HIV Vaccines, Other Diseases

Sep. 30, 2003

By Aaron Lorenzo

Angiotech Garners $218.8M With Follow-On Public Stock Offering

Sep. 29, 2003

By Aaron Lorenzo

Angiotech Garners $218.8M With Follow-On Public Stock Offering

Sep. 29, 2003

By Aaron Lorenzo